News

FDA expands approval of first gene therapy for rare form of muscular dystrophy

todayJune 20, 2024

share close
FDA expands approval of first gene therapy for rare form of muscular dystrophy
The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation.

​ The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation. Read More Breaking News, Latest News and Videos | CNN 

Written by:

Rate it
0%